A 50-year-old male patient presented to us with a permanent swelling of the upper lip, with a slight erythematic aspect, more evident at the right side; on palpation, there was an increased consistency, which felt granulose, and no pain was evoked, and the swelling had begun about 2 years ago The patient was in very good health, neither facial palsy nor fissurated tongue was present; He did not have any systemic complaints. He had been treated with oral corticosteroids and anti-histamines for a long time but without success. We performed a biopsy of the upper lip; the histological and immunofluorescence confirmed the clinical diagnosis of cheilitis granulomatosa (also called Miescher syndrome). The patients was treated with an intralesional injections of 40 mg of triamcinolone once a week for a total of three administration (Kenacort R, Bristol-Myers Squibb) with modified release associated to lidocaine 2% because the administration is very painful.8 We immediately noticed an improvement with resolution of the symptoms. Follow-up was performed at 1, 3, 6, and 12 months and no recurrence was found

Successful treatment of cheilitis granulomatosa with intralesional injection of triamcinolone

BACCI, CHRISTIAN;VALENTE, MARIALUISA
2010

Abstract

A 50-year-old male patient presented to us with a permanent swelling of the upper lip, with a slight erythematic aspect, more evident at the right side; on palpation, there was an increased consistency, which felt granulose, and no pain was evoked, and the swelling had begun about 2 years ago The patient was in very good health, neither facial palsy nor fissurated tongue was present; He did not have any systemic complaints. He had been treated with oral corticosteroids and anti-histamines for a long time but without success. We performed a biopsy of the upper lip; the histological and immunofluorescence confirmed the clinical diagnosis of cheilitis granulomatosa (also called Miescher syndrome). The patients was treated with an intralesional injections of 40 mg of triamcinolone once a week for a total of three administration (Kenacort R, Bristol-Myers Squibb) with modified release associated to lidocaine 2% because the administration is very painful.8 We immediately noticed an improvement with resolution of the symptoms. Follow-up was performed at 1, 3, 6, and 12 months and no recurrence was found
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/2448162
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 21
  • OpenAlex ND
social impact